Document and Entity Information
Document and Entity Information | Nov. 08, 2021 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 8, 2021 |
Entity Registrant Name | Stoke Therapeutics, Inc. |
Entity Central Index Key | 0001623526 |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity File Number | 001-38938 |
Entity Incorporation State Country Code | DE |
Entity Tax Identification Number | 47-1144582 |
Entity Address, Address Line One | 45 Wiggins Ave |
Entity Address City Or Town | Bedford |
Entity Address State Or Province | MA |
Entity Address Postal Zip Code | 01730 |
City Area Code | 781 |
Local Phone Number | 430-8200 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.0001 par value per share |
Trading Symbol | STOK |
Security Exchange Name | NASDAQ |